Integral Diagnostics Limited (ASX:IDX)

Market Cap	837.78M -4.5%
Revenue (ttm)	767.82M +56.3%
Net Income	14.03M +147.8%
EPS	0.04 +59.8%
Shares Out	372.35M
PE Ratio	59.97
Forward PE	15.87
Dividend	0.07 (3.24%)
Ex-Dividend Date	Mar 4, 2026

Volume	644,282
Average Volume	1,171,266
Open	2.280
Previous Close	2.250
Day's Range	2.240 - 2.290
52-Week Range	2.110 - 3.070
Beta	0.15
RSI	38.29
Earnings Date	Aug 25, 2026

About Integral Diagnostics

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. The company offers magnetic resonance imaging, positron emission tomography, computed tomography mammography, interventional radiology, ultrasound, and radiography, such as x-ray and EOS. Integral Diagnostics Limited was founded in 1967 and is headquartered in Melbourne, Australia.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1967
• Employees: 3,000
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: IDX